Skip to main content

and
Your search also matched 2 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

A pilot study imaging integrin αvβ3 with RGD PET/CT in suspected lung cancer patients

Include preview-only content
  1. Article

    Open Access

    A comparative study on the volume and localization of the internal gross target volume defined using the seroma and surgical clips based on 4DCT scan for external-beam partial breast irradiation after breast conserving surgery

    To explore the volume and localization of the internal gross target volume defined using the seroma and/or surgical clips based on the four-dimensional computed tomography (4DCT) during free-breathing.

    Yun Ding, Jianbin Li, Wei Wang, Suzhen Wang, **zhi Wang, Zhifang Ma in Radiation Oncology (2014)

  2. Article

    Open Access

    18F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer

    The study aims to investigate the role of 18F-alfatide positron emission tomography/computed tomography (PET/CT) in predicting the short-term outcome of concurrent chemoradiotherapy (CCRT) in patients with advanc...

    **aohui Luan, Yong Huang, Song Gao in European Journal of Nuclear Medicine and M… (2016)

  3. Article

    Open Access

    Dosimetric evaluation of four whole brain radiation therapy approaches with hippocampus and inner ear avoidance and simultaneous integrated boost for limited brain metastases

    To perform a dosimetric evaluation of four different simultaneous integrated boost whole brain radiotherapy modalities with hippocampus and inner ear avoidance in the treatment of limited brain metastases.

    Aijun Jiang, Weipeng Sun, Fen Zhao, Zhenxuan Wu, Dong** Shang in Radiation Oncology (2019)

  4. Article

    Open Access

    Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations

    Immune checkpoint inhibitors (ICIs) are most commonly used for melanoma and non-small cell lung cancer (NSCLC) patients. FAT atypical cadherin 1 (FAT1), which frequently mutates in melanoma and NSCLC. In this ...

    Wen**g Zhang, Yunfeng Tang, Yuxian Guo, Yujia Kong, Fuyan Shi in npj Precision Oncology (2022)